BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
25 results:

  • 1. Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide.
    Heo BY; Lee MW; Choi S; Jung Y; Pham TTD; Jang Y; Park JH; Kang S; Koh JS; Jo DY; Kwon J; Song IC
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626859
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
    Kaur H; Kaur G; Ali SA
    Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Suzuki T; Takei J; Fukasawa N; Suzuki K; Ogawa D; Yamamoto Y; Akasaki Y; Murayama Y; Shimoda M; Miyake K; Tanaka T
    World Neurosurg; 2023 Jul; 175():e1364-e1374. PubMed ID: 37187346
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
    Hosseinalizadeh H; Mahmoodpour M; Samadani AA; Roudkenar MH
    Med Oncol; 2022 Jun; 39(9):130. PubMed ID: 35716323
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary.
    Sue-A-Quan R; Patel PG; Shakfa N; Nyi MN; Afriyie-Asante A; Kang EY; Köbel M; Koti M
    Gynecol Oncol; 2021 Aug; 162(2):421-430. PubMed ID: 34088514
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
    Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
    J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor immune microenvironment in brain metastases from gynecologic malignancies.
    Gill CM; D'Andrea MR; Tomita S; Suhner J; Umphlett M; Zakashansky K; Blank SV; Tsankova N; Shrivastava RK; Fowkes M; Kolev V
    Cancer Immunol Immunother; 2021 Oct; 70(10):2951-2960. PubMed ID: 33713153
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.
    Steindl A; Alpar D; Heller G; Mair MJ; Gatterbauer B; Dieckmann K; Widhalm G; Hainfellner JA; Schmidinger M; Bock C; Müllauer L; Preusser M; Berghoff AS
    ESMO Open; 2021 Apr; 6(2):100057. PubMed ID: 33588158
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
    Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
    Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases.
    Clark PA; Sriramaneni RN; Jin WJ; Jagodinsky JC; Bates AM; Jaquish AA; Anderson BR; Le T; Lubin JA; Chakravarty I; Arthur IS; Heinze CM; Guy EI; Kler J; Klar KA; Carlson PM; Kim KM; Kuo JS; Morris ZS
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690669
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (ipex) syndrome: A systematic review.
    Park JH; Lee KH; Jeon B; Ochs HD; Lee JS; Gee HY; Seo S; Geum D; Piccirillo CA; Eisenhut M; van der Vliet HJ; Lee JM; Kronbichler A; Ko Y; Shin JI
    Autoimmun Rev; 2020 Jun; 19(6):102526. PubMed ID: 32234571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer.
    Park HS; Kwon WS; Park S; Jo E; Lim SJ; Lee CK; Lee JB; Jung M; Kim HS; Beom SH; Park JY; Kim TS; Chung HC; Rha SY
    J Immunother Cancer; 2019 Oct; 7(1):268. PubMed ID: 31639056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cytotoxicity of ultraviolet-C radiation on a heterogeneous population of human glioblastoma multiforme cells: Meta-analysis.
    Pronin S; Koh CH; Hughes M
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():158-163. PubMed ID: 30308311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
    Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
    J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms.
    Zapka P; Dörner E; Dreschmann V; Sakamato N; Kristiansen G; Calaminus G; Vokuhl C; Leuschner I; Pietsch T
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):119-127. PubMed ID: 29237087
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
    Goods BA; Hernandez AL; Lowther DE; Lucca LE; Lerner BA; Gunel M; Raddassi K; Coric V; Hafler DA; Love JC
    PLoS One; 2017; 12(9):e0181538. PubMed ID: 28880903
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
    Gururangan S; Reap E; Schmittling R; Kocak M; Reynolds R; Grant G; Onar-Thomas A; Baxter P; Pollack IF; Phillips P; Boyett J; Fouladi M; Mitchell D
    Cancer Immunol Immunother; 2017 Dec; 66(12):1589-1595. PubMed ID: 28825123
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
    Wei J; Nduom EK; Kong LY; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C; Fuller GN; Gilbert MR; Overwijk W; Calin GA; Heimberger AB
    Neuro Oncol; 2016 May; 18(5):639-48. PubMed ID: 26658052
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.
    Thomas AA; Fisher JL; Rahme GJ; Hampton TH; Baron U; Olek S; Schwachula T; Rhodes CH; Gui J; Tafe LJ; Tsongalis GJ; Lefferts JA; Wishart H; Kleen J; Miller M; Whipple CA; de Abreu FB; Ernstoff MS; Fadul CE
    Neuro Oncol; 2015 Jun; 17(6):801-9. PubMed ID: 25618892
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.
    Kmiecik J; Poli A; Brons NH; Waha A; Eide GE; Enger PØ; Zimmer J; Chekenya M
    J Neuroimmunol; 2013 Nov; 264(1-2):71-83. PubMed ID: 24045166
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.